Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

LSBio acquires Absolute Antibody Ltd.

Wednesday, December 23, 2020

LSBio (LSBio ™), a leading provider of antibodies and reagents for life science research, is pleased to announce the acquisition of Absolute Antibody, Ltd., based in Redcar, United Kingdom, and the subsidiary Kerafast. The terms of the transaction were not disclosed.

LSBio provides IHC validated antibodies / reagents and services to the global community of academic, pharmaceutical and biotech researchers. The Company has created a catalog of over 750,000 antibodies / reagents, assay kits, proteins and biochemicals and, with the acquisition of Absolute Antibody and Kerafast, further expands its product portfolio by adding a range of unique reagents and services in antibody segment.

Absolute Antibody is a specialist in antibody recombination technology and offers customized services for antibody sequencing, engineering and manufacturing of recombinants, as well as a unique catalog of antibodies / recombinants and Fc fusion proteins, engineered in new formats useful.

The original text of this announcement, written in the source language, is the authentic official version. Translations are offered solely for the convenience of the reader and must refer to the original text, which is the only legally valid text.

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024